Comparing effects of U50488H, prazosin and/or propranolol on cardiac hypertrophy induced by NE in rat.
- Author:
Gui-jun WANG
1
;
Yu-sheng YAO
;
Hong-xin WANG
Author Information
- Publication Type:Journal Article
- MeSH: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; pharmacology; Adrenergic alpha-1 Receptor Antagonists; pharmacology; Adrenergic beta-Antagonists; pharmacology; Animals; Animals, Newborn; Cardiomegaly; chemically induced; pathology; prevention & control; Cell Enlargement; drug effects; Cells, Cultured; Female; Male; Myocytes, Cardiac; cytology; Norepinephrine; Prazosin; pharmacology; Propranolol; pharmacology; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; agonists
- From: Chinese Journal of Applied Physiology 2010;26(1):82-85
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo demonstrate the inhibitory effect of kappa-opioid receptor activation by U50488H on hypertrophy induced by NE in cultured neonatal rat cardiac myocytes and compare its effect with that of prazosin and propranolol.
METHODSThe cellular proliferation was determined with crystal violet staining. The protein content was assayed with Lowry's method. The cardiomyocytes volumes were measured by computer photograph analysis system. The protein synthesis was assayed with [3H]-lencine incorporation method.
RESULTS(1) NE significantly induced the increase of protein content, [3H]-leucine incorporation and cell size without a concomitant increase in cell number in low serum medium. OThese responses were partially suppressed by prazosin or propranolol alone and completely abolished by both in combination. U50488H significantly inhibited the NE-induced increase of protein content, [3H]-leucine incorporation and cell size. The inhibitory effects of U50488H on NE-induced cardiac hypertrophy were greater than either prazosin or propranolol, but comparable to combination of both.
CONCLUSIONNE, acting via both alpha1- and beta-adrenergic pathway, stimulates myocyte hypertrophy. Stimulating kappa-opioid receptor significantly inhibits NE-induced cardiac hypertrophy, which may be related with alpha1- and beta1-adrenergic pathway.